FARE Peanut SLIT and Early Tolerance Induction

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Peanut HypersensitivityFood AllergyFood HypersensitivityPeanut Allergy
Interventions
DRUG

Liquid Peanut Extract

5000mcg/ml peanut protein

DRUG

Placebo Glycerin SLIT

pure glycerinated saline solution with caramel coloring to match color

Trial Locations (2)

27599

University of North Carolina at Chapel Hill, Chapel Hill

75235

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

Food Allergy Research & Education

OTHER

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

University of Texas Southwestern Medical Center

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT02304991 - FARE Peanut SLIT and Early Tolerance Induction | Biotech Hunter | Biotech Hunter